RWC-340B Press Statement on Recent Actions Taken by Drug Manufacturers

Here is a press statement from RWC-340B president Shannon Stephenson regarding the recent actions taken by drug manufacturers Lilly, Novartis, Merck, Sanofi, and Astra Zeneca.  In the statement, RWC-340B calls…

Manufacturers to Provide “340B Rebates” Through New Kalderos Software Platform

This week, Kalderos announced that it is launching its new “340B Pay” platform which, if implemented, would fundamentally change how the 340B drug discount program operates – shifting a manufacturer’s…